Excellent outcome of renal transplantation in patients with Fabry's disease

Transplantation

Volumn 69, Issue 11, 2000, Pages 2337-2339

  Ojo, Akinolou ^a   Meier Kriesche, Herwig Ulf ^a   Friedman, Gary ^a   Hanson, Julie ^a   Cibrik, Diane ^a   Leichtman, Alan ^a   Kaplan, Bruce ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSPHINGOLIPID;

ADULT; ARTICLE; CONTROLLED STUDY; FABRY DISEASE; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0034660663     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006150-00020     Document Type: Article

References (16)

1. Kornreich R, Bishop DF, Desnick RJ. Alpha galactosidase A gene rearrangements causing Fabry's disease. J Biol Chem 1990; 265: 9319.
2. Desnick RJ, Sweeley CC. Fabry's disease: α-Galactosidase A deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, et al., eds. The metabolic basis of inherited disease, 5th ed. New York: McGraw-Hill, 1983: 906.
3. Kramer W, Thromann J, Mueller K, Frenzel H. Progressive cardiac involvement by Fabry's disease despite successful renal allotransplantation. Int J Cardiol 1985; 7: 72.
4. Davison DM. Case reports of the Massachusetts General Hospital. N Engl J Med 1984; 310: 106.
5. Adler SG, Cohen AH, Glassock RJ. Secondary glomerular diseases. In: Brenner BM ed. The kidney, 5th ed. Philadelphia: WB Saunders, 1996: 1498.
6. Mosnier JF, Degott C, Bedrossian J, et al. Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation. Transplantation 1991; 51: 759.
7. Schweitzer EJ, Drachenberg CB, Bartlett ST. Living kidney donor and recipient evaluation in Fabry's disease. Transplantation 1992; 54: 924.
8. Popli S, Molnar ZV, Leehey DJ, et al. Involvement of renal allograft by Fabry's disease. Am J Nephrol 1987; 7: 316.
9. Donati D, Novario R, Gastaldi L. Natural history and treatment of uremia secondary to Fabry's disease: a European experience. Nephron 1987; 46: 353.
10. Kramer W, Thormann J, Mueller K, Frenzel H. Progressive cardiac involvement by Fabry's disease despite successful renal allotransplantation. Int J Cardiol 1985; 7: 72.
11. Sheth KJ, Roth DA, Adams MB. Early renal failure in Fabry's disease. Am J Kidney Dis 1983; 2: 651.
12. Maizel SE, Simmons RL, Kjellstrand C, Fryd DS. Ten-year experience in renal transplantation for Fabry's disease. Transplant Proc 1981; 13: 57.
13. Desnick RJ, Simmons RL, Allen KY, et al. Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery 1972; 72: 203.
14. Philippart M, Franklin SS, Gordon A. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation. Ann Intern Med 1972; 77: 195.
15. Friedlaender MM, Kopolovic J, Rubinger D, et al. Renal biopsy in Fabry's disease eight years after successful renal transplantation. Clin Nephrol 1987; 27: 206.
16. Peces R, Aguado S, Fernandez F, et al. Renal transplantation in Fabry's disease. Nephron 1989; 51: 294.